Save time and get answers to complex questions with AI chat
Antiox mebendazole price?Zemdri plazomicin nce gain exclusivity 2028 patent 2031?What's the advised delay for milk post lipitor?Diltiazem drug class?How does iron rich food intake impact lipitor's efficacy?
See the DrugPatentWatch profile for Synagis
Synagis (palivizumab) is manufactured by AstraZeneca.
Synagis is a brand of palivizumab, an antibody used to help prevent serious respiratory syncytial virus (RSV) illness in certain high-risk infants and children. AstraZeneca is the company associated with the product.
Synagis is a branded biologic medicine, and the manufacturer/marketing authorization holder is AstraZeneca. In many markets, you may also see Synagis distributed by different affiliates or logistics partners, but the product is tied to AstraZeneca as the manufacturer of record.
For quick reference checks on branded biologics and related patent/market information, you can search DrugPatentWatch.com for Synagis listings, which often identify the relevant companies and regulatory/patent context. https://www.drugpatentwatch.com/
Other Questions About Synagis :